
Medical oncologist @Matercancer via @MSK_DeptOfMed and @UCDMedicine
Dublin, IRE
Joined November 2018
- Tweets104
- Following665
- Followers370
- Likes309
Darren Cowzer retweeted
Congratulations @CowzerDarren. Great deep dive #biliarytractcancer #genomics outcomes and resistance! @MSK_DeptOfMed @MSKCancerCenter @MskccCMO @DSolit @GABOUALFA @EileenMOReilly
Now online: Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer doi.org/10.1158/1078-0432.CC…
Darren Cowzer retweeted
Zanidatamab in HER2-PositiveMetastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01
@JAMAOnc
doi.org/10.1001/jamaoncol.20…
👉IHC 3+: cORR 51.6% & mOS 18.1 mo
👉IHC 2+: cORR, 5.6% & mOS 5.2 mo
🧐Stong signal of efficacy in IHC3+, IHC is key for pts selection
Darren Cowzer retweeted
Final day operating in OR10 in the @Matersurgery with the legend that is Gerry McEntee today. Legacy in surgery is elusive. 34 years, 70 Registrars, 70+ SHO’s, 200+ Interns… IYKYK. Mo cheol thú. Thank you Gerry, it’s been an honour.
Darren Cowzer retweeted
🧬cfDNA in biliart tract cancers
@JCOPO_ASCO
📌OncoKB level 1/2 alterations in 25% of patients
📌High tissue concordance
📌May be prognostic
✅Another data reinforcing utility of ctDNA in BTCs
👉ascopubs.org/doi/10.1200/PO-…
@ASCO @curecc @PrecisionBTCnet #cancer #oncology #MedX #biliary @OncoAlert @realbowtiedoc
Darren Cowzer retweeted
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in BTC
@JCOPO_ASCO
doi.org/10.1200/PO-25-00355
🔎297 samples, 170 pts
👉Prognostic in part...
👉useful to understand resistance MOA
🧐 cfDNA-based NGS complementary to tissue NGS
@myESMO @EASLedu @ILCAnews
Darren Cowzer retweeted
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer.
Read the full article. brnw.ch/21wW1C0
Darren Cowzer retweeted
This retrospective study provides a comprehensive analysis of the clinical and genomic predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma. @cowzerdarren
doi.org/10.1093/oncolo/oyae1…
Darren Cowzer retweeted
Starting at 11:30 a.m. PST: @ASCO #GI25 poster sessions! Stop by the West Hall for #pancreaticcancer and #biliarytractcancer advances by @HardingJJMD, @EileenMOReilly, @rohit_thum, @Layalmahmasani, and more! @mskcancercenter bit.ly/3WB5q7J
Darren Cowzer retweeted
Featured today by @MSKLibrary: Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
#Clinicogenomics #HepatocellularCarcinoma #Immunotherapy #CancerResearch #PredictiveBiomarkers #PrecisionMedicine #CancerOutcomes #Oncology
@CowzerDarren @JoanneF_Chou @hswalch @ferguskeane2 @DrRichardDo @HoomanYarMD @DrErinjeri
dx.doi.org/10.1093/oncolo/oy…
Darren Cowzer retweeted
Delighted to announce Goodman Fellowship opportunity in Phase 1 Oncology for medical oncology trainees in Ireland @MaterCancer. DM us here @STARTDublinPh1 if interested
Darren Cowzer retweeted
Featured today by @MSKLibrary: A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier
#study #tumors #hiddengenomeclassifier @ThomasBoernerMD @drillybit @carliesigel @AndreaCercek @GABOUALFA @ciacobu @CowzerDarren @hswalch @TheVinodLab @BasGrootKoerkam @drpeterkingham @KevinCSoaresMD @MichaelDAngeli2 @Jeffrey_Drebin @HardingJJMD
dx.doi.org/10.1158/1078-0432…
Darren Cowzer retweeted
It was clear to see the enormous impact of Pat Smullen's legacy at @curraghrace this Saturday.
The funds raised by Pat's family, friends, and the horse racing community since 2019 have made new clinical trials and treatment options for patients with #PancreaticCancer possible.
Great to have mentors and colleagues @ImaneDika Geoff Ku from @MSK_DeptOfMed here presenting in Ireland @CancerGathering
Darren Cowzer retweeted
🩸Data from @CowzerDarren, @HardingJJMD, et al. showing how NGS of #cfDNA in HCC represents an alternative to tissue-based profiling given the high tumor-plasma NGS concordance. ➡️ brnw.ch/21wE02v #gicsm
Darren Cowzer retweeted
Excited to share our latest work in @jitcancer! @DavidFaleckMD @SteveMaronMD @CowzerDarren @YJanjigianMD @MSKCancerCenter @MSK_DeptOfMed
New #JITC article: Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors bit.ly/3SiwNSE @CowzerDarren @DavidFaleckMD @MLaszkowskaMD
Darren Cowzer retweeted
👀 Check out what’s popular this week in #JCOPO:
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced #HepatocellularCarcinoma ➡️ brnw.ch/21wDi3w @CowzerDarren @HardingJJMD #cfDNA #NGS
Darren Cowzer retweeted
First-line regorafenib with nivo & FOLFOX in GEJ/GC in the USA: a single-arm, single-centre, phase 2 trial
@TheLancetOncol
doi.org/10.1016/S1470-2045(2…
👉ORR: 76%, mPFS: 13mo, mOS: nr., regardless of PD-L1 CPS status
👉Efficacy, but also toxicity...
🧐Looks promising, ph-3 planned
@myESMO @OncoAlert
Darren Cowzer retweeted
Great to see the team @MSKCancerCenter building on the CALGB 80803 PET-directed therapy trial with the addition of immunotherapy. Another promising development in the fight against cancer 🎉
In this Phase Ib/II trial: The addition of #durvalumab to induction FOLFOX and PET directed chemoradiation prior to surgery is safe for LA esophageal adenocarcinoma, with a high rate of pathologic response, as well as encouraging survival data. #esosm
journals.lww.com/annalsofsur…
Proud to see this in print. Only possible with the brilliant mentorship of @HardingJJMD and support of all STGI team @MSK_DeptOfMed @YJanjigianMD @GABOUALFA @EileenMOReilly & Co @JCOPO_ASCO
Congratulations to @CowzerDarren and team @MskccCMO, @MFBerger1, @DSolit, @Gaboualfa, and @HardingJJMD! Their paper on tumor mutation profiling of circulating cell-free DNA in people with #livercancer was published today in @JCOPO_ASCO.
Read it here: ascopubs.org/doi/abs/10.1200…
Darren Cowzer retweeted
🌍 <1 hour until TONIGHT’S cross-continental #TumorBoardTuesday
🪚@KlempnerSam @CowzerDarren join to cut deep into #GastricCancer + CLAUDIN 18.2
🪵Brush off the sawdust, throw on the oil, & grab a Guinness while you check out these #CME
👇🏽See y’all soon
nitter.cf/TumorBoardTues/status/…
Replying to @TumorBoardTues
#PreTest Q1️⃣ #TumorBoardTuesday
Free #CME integrityce.com/TBT2023
➡️B4 @KlempnerSam & @CowzerDarren🗣️Novel Txs & Claudin 18.2🎯💊for Gastric Ca, test your🧠with these Q’s
🤔What Tx would you offer a 56yo♂️with pMMR, HER2–, PD-L1+ (CPS = 1), CLDN18.2+ (>75%) met gastric🦀❓
5%Bemarituzumab + chemo
8%Chemo
19%Nivolumab + chemo
69%Zolbetuximab + chemo
64 votes • Final results




































